Milestone Pharmaceuticals Inc (MIST NASDAQ) stock market data APIs
$1.5543
0.18(11.6%)
as of July 11, 2025
Try our APIs with
free plan!
Milestone Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Prev. Close
1.5543
Open
1.737
High
1.9469
Low
1.469
52 wk Range
0.625-2.75
Market Cap
83 404 K
Shares Outstanding
53 464 K
EPS
-0.31
Beta
0.917
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Milestone Pharmaceuticals Inc data using free add-ons & libraries
Get Milestone Pharmaceuticals Inc Fundamental Data
Milestone Pharmaceuticals Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -52 045 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-12
- EPS/Forecast: -0.195
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Milestone Pharmaceuticals Inc News
New
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.63%
Investing.com – U.S. stocks were lower after the close on Friday, as losses in the Telecoms, Healthcare and Financials sectors led shares lower. At the close in NYSE, the Dow Jones Industrial Avera...
Milestone Pharmaceuticals Launches Public Offering To Support Etripamil Development
(RTTNews) - Milestone Pharmaceuticals Inc. (MIST) has initiated an underwritten public offering of its common shares, Series A and Series B warrants for purchasing common shares, and, for certain inve...
Milestone Pharmaceuticals plunges after pricing $52.5M offering
* Milestone Pharmaceuticals (NASDAQ:MIST [https://seekingalpha.com/symbol/MIST]) shares fell nearly 38% on Friday after the company priced an offering to raise approximately $52.5 million. * The o...
Milestone Pharmaceuticals prices $52.5 million public offering
MONTREAL/CHARLOTTE - Milestone Pharmaceuticals Inc. (NASDAQ:MIST), a biopharmaceutical company with a market capitalization of $118 million, has priced its previously announced underwritten public off...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
